个性化文献订阅>期刊> Bioorganic & Medicinal Chemistry
 

Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl beta-D-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia

  作者 FUSHIMI NOBUHIKO; FUJIKURA HIDEKI; SHIOHARA HIROAKI; TERANISHI HIROTAKA; SHIMIZU KAZUO; YONEKUBO SHIGERU; OHNO KOHSUKE; MIYAGI TAKASHI; ITOH FUMIAKI; SHIBAZAKI TOSHIHIDE; TOMAE MASAKI; ISHIKAWATAKEMURA YUKIKO; NAKABAYASHI TAKESHI; KAMADA NOBORU; OZAWA TOMONAGA; KOBAYASHI SUSUMU; ISAJI MASAYUKI  
  选自 期刊  Bioorganic & Medicinal Chemistry;  卷期  2012年20-22;  页码  6598-6612  
  关联知识点  
 

[摘要]Sodium glucose co-transporter 1 (SGLT1) plays a dominant role in the absorption of glucose in the gut and is considered a promising target in the development of treatments for postprandial hyperglycemia. A series of 4-benzyl-1H-pyrazol-3-yl beta-D-glucopyranoside derivatives have been synthesized, and its inhibitory activity toward SGLTs has been evaluated. By altering the substitution groups at the 5-position of the pyrazole ring, and every position of the phenyl ring, we studied the structure-activity relationship (SAR) profiles and identified a series of potent and selective SGLT1 inhibitors. Representative derivatives showed a dose-dependent suppressing effect on the escalation of blood glucose levels in oral mixed carbohydrate tolerance tests (OCTT) in streptozotocin-nicotinamide-induced diabetic rats (NA-STZ rats). (C) 2012 Elsevier Ltd. All rights reserved.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内